An economic evaluation of voriconazole versus amphotericin B for the treatment of invasive aspergillosis in Canada

Por Rotstein, Coleman, Laverdière, Michel, Marciniak, Anne, Ali, Farzad
Publicado em 2004

Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice

Por Weycker Derek, Danel Aurelie, Marciniak Anne, Bendall Kate, Lipsitz Michael, Pettengell Ruth
Publicado em 2012-08-01

Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice

Por Weycker, Derek, Danel, Aurelie, Marciniak, Anne, Bendall, Kate, Lipsitz, Michael, Pettengell, Ruth
Publicado em 2012

Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications

Por Freemantle, Nick, Cooper, Cyrus, Roux, Christian, Díez-Pérez, Adolfo, Guillemin, Francis, Jonsson, Bengt, Ortolani, Sergio, Pfeilschifter, Johannes, Horne, Rob, Kakad, Shilpa, Shepherd, Susan, Möller, Gerd, Marciniak, Anne, Martinez, Luc
Publicado em 2010